Clinical Pharmacy and Pharmacotherapeutics

<div><!--block-->The second Edition of Clinical Pharmacy and Pharmacotherapeutics is a New Book which covers many general and important topics. The color style has increased the clarity of presentation and total information content.This edition emphasizes several new themes which includes General Topics, Drugs used in Different Life Stages, Case Studies of Different Disorders, Problems related to Clinical Pharmacotherapeutics. Major features that make this Book particularly useful in integrated curricula include sections that specifically address the clinical choice and uses of drugs in patients and monitoring of their effects is an integral part of this text. This sequence of new chapters builds new information on a foundation of information already assimilated. However, these new chapters can be used equally well in courses and curricula that present these topics in a different sequence. Within each chapter, emphasis is placed on discussion of drug groups and prototypes rather than offering repetitive detail about individual drugs.<strong>Significance of this book includes:</strong>Different Case Studies pertaining to wide variety of diseases are discussed; explicit answers and discussions are provided in the text of Part IV.Many important new chapters were added.New illustrations with full color were provided with significant information which would help and clarify important concepts.Expanded coverage of new topics in Part I, II & III were highlighted<br><strong>Contents:</strong> <strong>PART – I GENERAL 1.</strong> Introduction to Clinical Pharmacy <strong>2.</strong> Communication Skills for Clinical Pharmacists <strong>3.</strong> Medication History Interview <strong>4.</strong> Evidence-Based Medicine <strong>5. </strong>Pharmaceutical Care Plan <strong>6.</strong> Rational Drug Use <strong>7.</strong> Polypharmacy and Medication Errors <strong>8.</strong> Drug Interactions <strong>9.</strong> Adverse Drug Reactions (ADR) <strong>10.</strong> The Role of the Pharmacist in Disease Management <strong>11.</strong> Case Presentation <strong>12.</strong> Patient Counseling <strong>13.</strong> Parenteral Nutrition <strong>14.</strong> Pharmacovigilance <strong>15.</strong> Essential Drugs <strong>16.</strong> Therapeutic Drug Monitoring <strong>PART – II LIFE STAGES 17. </strong>Posology <strong>18.</strong> Neonates and Paediatrics <strong>19.</strong> Drug Therapy in Geriatric Patients <strong>20.</strong> Dose and Dosage Schedule of Digoxin <strong>21.</strong> Drug Dosing Adjustments in Patients with Renal Failure <strong>PART – III PHARMACOTHERAPEUTICS GASTRO INTESTINAL DISORDERS 22. </strong>Peptic Ulcer Disease <strong>23.</strong> Inflammatory Bowel Disease <strong>24.</strong> Diarrhea <strong>25.</strong> Constipation <strong>26.</strong> Nausea and Vomiting <strong>27.</strong> Gastro Esophageal Reflux Disorder <strong>28.</strong> Ascites <strong>29.</strong> Dysphagia <strong>HEPATIC DISORDERS 30. </strong>Liver Disease <strong>31.</strong> Alcoholic Hepatitis <strong>32.</strong> Hepatitis <strong>33.</strong> Drug Induced Hepatotoxicity <strong>34.</strong> Pancreatitis <strong>RENAL DISORDERS 35.</strong> Acute Renal Failure <strong>36.</strong> Chronic Kidney Disease <strong>37.</strong> Benign Prostatic Hyperplasia (BPH) <strong>38.</strong> Diabetic Nephropathy <strong>39.</strong> Urinary Stone Disease <strong>CARDIOVASCULAR DISORDERS 40.</strong> Hypertension <strong>41.</strong> Heart Failure <strong>42.</strong> Arrhythmia <strong>43.</strong> Dyslipidemia <strong>44.</strong> Coronary Artery Disease <strong>45.</strong> Ischaemic Heart Disease <strong>46.</strong> Atrial Flutter <strong>47.</strong> Hypertrophic Cardiomyopathy <strong>RESPIRATORY DISORDERS 48.</strong> Asthma <strong>49.</strong> Chronic Obstructive Pulmonary Disease <strong>50.</strong> Pulmonary Hypertension <strong>51.</strong> Cystic Fibrosis <strong>52.</strong> Hemoptysis <strong>NEUROLOGICAL AND PSYCHOLOGICAL DISORDERS </strong><br /><strong>53.</strong> Insomnia and Anxiety <strong>54.</strong> Schizophrenia <strong>55.</strong> Epilepsy <strong>56.</strong> Parkinson’s Disease <strong>57.</strong> Pain <strong>58.</strong> Alzheimer’s Disease (AD) <strong>59.</strong> Anxiety Disorders <strong>60.</strong> Major Depressive Disease <strong>61.</strong> Headache <strong>62.</strong> Stroke <strong>63.</strong> Obsessive Compulsive Disorder <strong>INFECTIONS 64.</strong> Respiratory Tract Infections <strong>65.</strong> Infective Meningitis <strong>66.</strong> Infective Meningitis <strong>67.</strong> Tuberculosis <strong>68.</strong> HIV Infection <strong>69.</strong> GI Infection <strong>70.</strong> Sexually Transmitted Diseases <strong>71.</strong> Sepsis and Septic Shock <strong>PROTOZOAL INFECTIONS 72.</strong> Malaria <strong>73.</strong> Filaria <strong>ENDOCRINE DISORDERS </strong><br /> <strong>74.</strong> Thyroid Disorders <strong>75.</strong> Parathyroid Disorders <strong>76.</strong> Diabetes Mellitus <strong>77.</strong> Cushing’s Syndrome <strong>78.</strong> Addisons Disease <strong>79.</strong> Pheochromocytoma <strong>OBSTETRICS AND GYNECOLOGICAL DISORDERS </strong><br /> <strong>80.</strong> Menstrual Cycle Disorders <strong>81.</strong> Menopause <strong>82.</strong> Drug Therapy in Pregnancy <strong>83.</strong> Drug Therapy in Lactation <strong>MALIGNANT DISORDERS 84.</strong> Leukemia <strong>85.</strong> Lymphoma <strong>86.</strong> Breast Cancer <strong>87.</strong> Prostate Cancer <strong>88.</strong> Colorectal Cancer <strong>RHEUMATIC DISORDERS 89.</strong> Rheumatoid Arthritis <strong>90.</strong> Osteoarthritis <strong>91.</strong> Gout and Hyperuricemia <strong>EYE DISORDERS </strong><br /> <strong>92.</strong> Glaucoma <strong>93.</strong> Diabetic Retinopathy <strong>SKIN DISORDERS </strong><br /> <strong>94.</strong> Psoriasis <strong>95.</strong> Skin Disorders and Cutaneous Drug Reactions <strong>96.</strong> Acne Vulgaris <strong>MISCELLANEOUS 97.</strong> Male Sexual Dysfunction <strong>98.</strong> Drug Dependence and Drug Abuse <strong>99.</strong> Nutraceuticals <strong>100. </strong>Pharmacoeconomics <strong>101.</strong> Pharmacogenomics <strong>PART – IV CASE STUDIES 102. </strong>Cardiovascular Case Studies <strong>103.</strong> Respiratory Case Studies <strong>104.</strong> Central Nervous System Case Studies <strong>105.</strong> Gastro Intestinal Case Studies <strong>106.</strong> Infection Case Studies <strong>107.</strong> Endocrine Case Studies <strong>108.</strong> Malignant Case Studies <strong>109.</strong> Skin Case Studies <strong>110.</strong> Liver Case Studies <strong>111.</strong> Miscellaneous Case Studies <strong>PART – V PROBLEMS </strong><br /> <strong>112.</strong> Problems based on Paediatric Dose Calculations <strong>113.</strong> Problems based on Clearance <strong>114.</strong> Problems based on Absorption Half Life <strong>115.</strong> Problems based on Elimination Half life <strong>116.</strong> Problems based on Area Under Curve (AUC) <strong>117.</strong> Problems based on Wagner Nelson Method <strong>118.</strong> Problems based on One Compartment Oral Absorption <strong>119.</strong> Problems based on Two Compartment Model IV Bolus <strong>120.</strong> Problems based on Non Compartmental Analysis.<br /></div>